You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Melbourne, Australia-based Sienna Cancer Diagnostics announced today that it has signed an agreement to acquire US-based Sevident's NET molecular capture platform.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.